Aerie Pharmaceuticals Inc


AERI

Price

10.64


Change

0.42


High

10.67


Low

10.04


Avg Volume

1,061,732


PE Ratio

-2.95


52 Week High

21.3


52 Week Low

9.15



Profile

Aerie Pharmaceuticals Inc. is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.